Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain

Neuroscience

Volumn 139, Issue 4, 2006, Pages 1397-1403

  du Bois, T M ^a,b   Deng, C ^a,b   Bell, W ^b   Huang, X F ^a,b  

^a Neuroscience Institute for Schizophrenia and Allied Disorders   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

brain; polyunsaturated fat; schizophrenia

Indexed keywords

FATTY ACID; KETANSERIN; MESULERGINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PAROXETINE; SATURATED FATTY ACID; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CAUDATE NUCLEUS; CONTROLLED STUDY; HIPPOCAMPUS; IMAGING AND DISPLAY; LIPID DIET; LOW FAT DIET; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; RECEPTOR BINDING; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; ERGOLINES; FATTY ACIDS; KETANSERIN; MALE; PAROXETINE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 33646161454     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.068     Document Type: Article

References (54)

1. Arora R.C., and Meltzer H.Y. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 85 (1991) 19-29
2. Arranz B., Rosel P., Sarro S., Ramirez N., Duenas R., Cano R., Maria Sanchez J., and San L. Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res 118 (2003) 165-174
3. Arvindakshan M., Ghate M., Ranjekar P.K., Evans D.R., and Mahadik S.P. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62 (2003) 195-204
4. Ayton A.K., Azaz A., and Horrobin D.F. A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 205-209
5. Bennett Jr. J.P., Enna S.J., Bylund D.B., Gillin J.C., Wyatt R.J., and Snyder S.H. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36 (1979) 927-934
6. Bourre J.M., Pascal G., Durand G., Masson M., Dumont O., and Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem 43 (1984) 342-348
7. Burnet P.W., Eastwood S.L., and Harrison P.J. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15 (1996) 442-455
8. Casado V., Mallol J., Canela E.I., Franco R., and Lluis C. Modulation of adenosine agonist [3H]N6-(R)-phenylisopropyladenosine binding to pig brain cortical membranes by changes of membrane fluidity and of medium physicochemical characteristics. Eur J Pharmacol Mol Pharmacol Sect 225 (1992) 7-14
9. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A.M., Besnard J.C., and Durand G. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 128 (1998) 2512-2519
10. Cunha R.A., Constantino M.D., Fonseca E., and Ribeiro J.A. Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur J Biochem 268 (2001) 2939-2947
11. Dean B., and Hayes W. Decreased frontal cortical serotonin2A receptors in schizophrenia. Schizophr Res 21 (1996) 133-139
12. Dean B., Opeskin K., Pavey G., Naylor L., Hill C., Keks N., and Copolov D.L. [3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia. J Neurochem 64 (1995) 1197-1202
13. Delion S., Chalon S., Guilloteau D., Besnard J.C., and Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66 (1996) 1582-1591
14. Delion S., Chalon S., Herault J., Guilloteau D., Besnard J., and Durand G. Chronic dietary (alpha)-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124 (1994) 2466-2476
15. du Bois T.M., Bell W., Deng C., and Huang X.-F. A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain. J Chem Neuroanat 29 (2005) 282-288
16. Fenton W.S., Dickerson F., Boronow J., Hibbeln J.R., and Knable M. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158 (2001) 2071-2074
17. Govitrapong P., Chagkutip J., Turakitwanakan W., and Srikiatkhachorn A. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment. Psychiatry Res 96 (2000) 41-50
18. Gurevich E.V., and Joyce J.N. Alterations in the cortical serotonergic system in schizophrenia. a postmortem study. Biol Psychiatry 42 (1997) 529-545
19. Habert E., Graham D., Tahroui L., Claustre Y., and Langer S.Z. Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118 (1985) 107-114
20. Hashimoto T., Nishino N., Nakai H., and Tanaka C. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48 (1991) 355-363
21. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 30 (2006) 203-214
22. Horrobin D.F., Fenton W.S., Dickerson F., Boronow J., Hibbeln J.R., and Knable M.B. Omega-3 fatty acid for schizophrenia. Dr. Fenton and colleagues reply. Am J Psychiatry 160 (2003) 188
23. Huang X.-F., Huang X., Han M., Chen F., Storlien L., and Lawrence A.J. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity. a quantitative autoradiography study. Brain Res 1018 (2004) 227-235
24. Kaye W., Gendall K., and Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry 44 (1998) 825-838
25. Kodas E., Page G., Zimmer L., Vancassel S., Guilloteau D., Durand G., and Chalon S. Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents. Neurosci Lett 321 (2002) 95-99
26. Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., and Kleinman J.E. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 50 (1993) 810-818
27. Lewis R., Kapur S., Jones C., DaSilva J., Brown G.M., Wilson A.A., Houle S., and Zipursky R.B. Serotonin 5-HT2 receptors in schizophrenia. a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. Am J Psychiatry 156 (1999) 72-78
28. Li Q., Wichems C.H., Ma L., Van de Kar L.D., Garcia F., and Murphy D.L. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem 84 (2003) 1256-1265
29. Marteinsdottir I., Horrobin D.F., Stenfors C., Theodorsson E., and Mathe A.A. Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain. Prog Neuropsychopharmacol Biol Psychiatry 22 (1998) 1007-1021
30. Meltzer H.Y., Li Z., Kaneda Y., and Ichikawa J. Serotonin receptors. their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 1159-1172
31. Middlemiss D.N., Price G.W., and Watson J.M. Serotonergic targets in depression. Curr Opin Pharmacol 2 (2002) 18-22
32. Mita T., Hanada S., Nishino N., Kuno T., Nakai H., Yamadori T., Mizoi Y., and Tanaka C. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21 (1986) 1407-1414
33. Otkem H.A., and Apaydin S. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors. Neurobiology 6 (1998) 323-332
34. Pandey S.C., Sharma R.P., Janicak P.G., Marks R.C., Davis J.M., and Pandey G.N. Platelet serotonin-2 receptors in schizophrenia. Effects of illness and neuroleptic treatment. Psychiatry Res 48 (1993) 57-68
35. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press Inc, London
36. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression. rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 69 (2003) 477-485
37. Peet M., Brind J., Ramchand C.N., Shah S., and Vankar G.K. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 49 (2001) 243-251
38. Peet M., Horrobin D.F., and E.E.M.S. Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 36 (2002) 7-18
39. Peet M., Laugharne J.D., Mellor J., and Ramchand C.N. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot Essent Fatty Acids 55 (1996) 71-75
40. Peet M., and Mellor J. Double-blind placebo controlled trial of N-3 polyunsaturated fatty acids as an adjunct to neuroleptics. Schizophr Res 29 (1998) 160-161
41. Pietzsch H.-J., Scheunemann M., Kretzschmar M., Elz S., Pertz H.H., Seifert S., Brust P., Spies H., Syhre R., and Johannsen B. Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor. Nucl Med Biol 26 (1999) 865-875
42. Puri B.K., and Richardson A.J. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Arch Gen Psychiatry 55 (1998) 188-189
43. Quirk K., Lawrence A., Jones J., Misra A., Harvey V., Lamb H., Revell D., Porter R.H.P., and Knight A.R. Characterisation of agonist binding on human 5-HT2C receptor isoforms. Eur J Pharmacol 419 (2001) 107-112
44. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., and Garnovskaya M.N. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92 (2001) 179-212
45. Reivich M., Amsterdam J.D., Brunswick D.J., and Yann Shiue C. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. J Affect Disord 82 (2004) 321-327
46. Shah S., Vankar G.K., Telang S.D., Ramchand C.N., and Peet M. Eicosapentaenoic acid (EPA) as an adjunct in the treatment of schizophrenia. Schizophr Res 29 (1998) 158
47. Simpson M.D.C., Lubman D.I., Slater P., and William Deakin J.F. Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia. Biol Psychiatry 39 (1996) 919-928
48. Spector A.A., and Yorek M.A. Membrane lipid composition and cellular function. J Lipid Res 26 (1985) 1015-1035
49. Sumiyoshi T., Stockmeier C.A., Overholser J.C., Dilley G.E., and Meltzer H.Y. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708 (1996) 209-214
50. Tiihonen J., Keski-Rahkonen A., Lopponen M., Muhonen M., Kajander J., Allonen T., Nagren K., Hietala J., and Rissanen A. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55 (2004) 871-873
51. Whitaker P.M., Crow T.J., and Ferrier I.N. Tritiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38 (1981) 278-280
52. Yao J.K., Magan S., Sonel A.F., Gurklis J.A., Sanders R., and Reddy R.D. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 171-176
53. 3H]spiperone binding in the anterior cingulate cortex of schizophrenia patients. an autoradiographic study. Neuroscience 109 (2002) 709-716
54. Zimmer L., Delion-Vancassel S., Durand G., Guilloteau D., Bodard S., Besnard J.C., and Chalon S. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41 (2000) 32-40